跳至主要内容
临床试验/NCT00524472
NCT00524472已完成不适用

The Effect of Hyperinsulinemic Glucose Control on Outcomes Following Cardiac Surgery

The Cleveland Clinic4 个研究点 分布在 2 个国家目标入组 1,439 人开始时间: 2007年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,439
试验地点
4
主要终点
Any Major Morbidity/30-day Mortality

研究概览

简要总结

Patients undergoing cardiac surgery will be randomized into one of two groups. Group A will be administered insulin using the hyperinsulinemic-normoglycemic clamp to normalize blood glucose levels intra-operatively. Group B will be administered insulin at the standard of care levels established by the participating institution. Patients will be followed at 10 days, 15 days and one year post-operatively.

详细描述

Using a randomized, controlled design, we propose to test the primary hypothesis that normalization of blood glucose using a hyperinsulinemic-normoglycemic clamp technique reduces the risk of a composite outcome (one or more) of 30-day postoperative mortality and serious postoperative cardiac, renal, neurologic, and infectious postoperative complications in patients undergoing cardiac surgery.

Our secondary hypothesis is that hyperinsulinemic normoglycemic therapy will reduce length of stay in intensive care unit, atrial dysrhythmias, creatinine elevation, hospital readmission, all-cause and cardiac one-year mortality.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-90 years old
  • Scheduled for cardiac surgery requiring cardiopulmonary bypass

排除标准

  • Off-pump surgical procedures
  • Anticipated deep hypothermic circulatory arrest
  • In available, baseline cardiac troponin I (>0.5 ng/L) or troponin T (> 0.1 ng/mL) levels (at RVH or CC, respectively)
  • Any contraindications to the proposed interventions
  • Active infection, including patients with endocarditis or infected pacemaker leads.
  • Any infection requiring long- term antibiotics ( > 14 days)
  • kidney disease requiring renal replacement therapy

结局指标

主要结局

Any Major Morbidity/30-day Mortality

时间窗: within 30 days post surgery

a composite (any versus none) of the following major postoperative complications occurring: 1. all-cause postoperative mortality 2. failure to wean from cardiopulmonary bypass or postoperative low cardiac index requiring mechanical circulatory support with intraaortic balloon counterpulsation, ventricular assist device, and/or extracorporeal mechanical oxygenation 3. serious postoperative infection 4. acute postoperative kidney injury requiring renal replacement therapy; 5. new postoperative focal or global neurologic deficit.

次要结局

  • Post Operative Atrial Fibrillation(15 - 30 days post operative)
  • Duration of Intensive Care Stay(ICU stay hours during hospital stay after surgery, on average of 25 hours)
  • a Composite of Minor Postoperative Complications(within 30 days after surgery)
  • Duration of Hospitalization(starting post operative day one to discharge from hospital, on an average of 8 days)
  • All-cause Mortality(one year post operative)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验